Limonene on Regulating Metabolism-related Fatty Liver Disease (MAFLD) and Analysis of TCM Constitution
Status:
Completed
Trial end date:
2021-10-25
Target enrollment:
Participant gender:
Summary
The prevention and treatment of metabolic-related fatty liver disease (MAFLD) involves many
fields in preventive medicine and clinical medicine. So far, western medicine has not yet
completed the elucidation of the mechanism of this type of disease, and there is a lack of
effective therapeutic drugs.The purpose of this study was to evaluate the effectiveness and
safety of limonene capsules (marketed product in China) in the treatment of metabolic-related
fatty liver disease and related lipid-lowering mechanisms.
Phase:
Early Phase 1
Details
Lead Sponsor:
Hongsheng Tan
Collaborators:
Hongqiao International Institute of Medicine, Shanghai Tongren Hospital and Faculty of Public Health, Shanghai Jiao Tong University School of Medicine Longhua Hospital Shanghai Shen Kang Hospital Development Center